Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges
Oleksandr Zagorodko1, Juan José Arroyo-Crespo1, Vicent J Nebot1,2
1Polymer Therapeutics Laboratory, Centro de Investigación Príncipe Felipe, Valencia, 46012, Spain.
Synthetic polypeptides offer versatile drug delivery platforms, but their full potential is limited by complex design parameters. This review explores structure-property correlations to guide the development of advanced polypeptide drug delivery systems.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery
Background:
- Synthetic polypeptides and polyamino acids are versatile platforms for advanced drug delivery.
- The complex interplay of physico-chemical and structural parameters hinders sophisticated design of polypeptide conjugates.
- Achieving the full potential of these systems requires a deeper understanding of structure-property-behavior relationships.
Purpose of the Study:
- To review the role of various parameters in designing polypeptide-based drug delivery architectures.
- To delineate correlations between the structure, properties, and in vivo behavior of polypeptide conjugates.
- To provide insights for the sophisticated directional design of advanced polypeptide drug delivery systems.
Main Methods:
- Literature review focusing on synthetic polypeptides and polyamino acids in drug delivery.
- Analysis of structure-property relationships in polypeptide conjugates.
- Discussion of biological behavior influenced by physico-chemical parameters.
Main Results:
- Identified key physico-chemical and structural parameters influencing polypeptide conjugate design.
- Highlighted the complexity and interconnectedness of these parameters.
- Established basic correlations between structure, properties, and biological performance.
Conclusions:
- Understanding structure-property-biological behavior correlations is crucial for optimizing polypeptide drug delivery systems.
- Sophisticated design requires addressing the complex interplay of multiple parameters.
- Further research into these correlations will unlock the full potential of polypeptide-based drug delivery.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Phase II Conjugation Reactions: Overview
Modified-Release Drug Delivery Systems: Site-Targeted
